[Is iron important in heart failure?]

Area of Science:

• Cardiology
• Internal Medicine
• Biochemistry

Background:

• Iron deficiency is a common comorbidity in chronic heart failure (CHF).
• It is linked to poorer patient prognosis, including reduced quality of life and increased rehospitalizations.
• Iron metabolism in CHF is complex, with distinctions between absolute and functional iron deficiency.

Purpose of the Study:

• To highlight the significance of iron deficiency in CHF.
• To discuss the current understanding of iron metabolism in CHF patients.
• To review the treatment strategies for iron deficiency in CHF.

Main Methods:

• Review of existing literature and clinical trial data on iron deficiency in CHF.
• Analysis of the prevalence and impact of iron deficiency and anemia in CHF.
• Evaluation of treatment efficacy, focusing on intravenous iron administration.

Main Results:

• Iron deficiency, rather than anemia, is critically associated with worse outcomes in CHF.
• Intravenous iron administration has shown positive results in clinical trials like FERRIC HF, FAIR HF, and CONFIRM HF.
• Per-oral iron treatment has less established efficacy compared to intravenous iron.

Conclusions:

• Addressing iron deficiency is crucial for improving the prognosis of patients with chronic heart failure.
• Intravenous iron therapy is a promising treatment approach for iron deficiency in CHF.
• Further research is needed, as current clinical trials have not yet analyzed mortality influences.